All News
Filter News
Found 2,611 articles
-
SuperSonic Imagine To Present At Cowen and Company 35th Annual Health Care Conference On March 4, 2015
3/2/2015
-
Genetic Technologies Limited Appoints Eutillio Buccilli As Chief Executive Officer
2/26/2015
-
Nektar Therapeutics (CA) Announces Start Of Phase 3 SUMMIT-07 Study Of NKTR-181 In Patients With Chronic Low Back Pain
2/25/2015
-
Sunshine Heart Receives FDA Approval For Interim Analysis Of U.S. Pivotal Trial Of C-Pulse Heart Assist System
2/25/2015
-
Achaogen To Present At The Cowen and Company 35th Annual Health Care Conference On March 3, 2015
2/25/2015
-
Accelerate Diagnostics To Present At The Cowen and Company 35th Annual Health Care Conference On March 4, 2015
2/25/2015
-
PharmaCyte Biotech's Scientific Advisory Board Chairman Publishes Review Article On The Pathology Of Pancreatic Cancer
2/24/2015
-
Sunshine Heart To Present At The Cowen and Company 35th Annual Health Care Conference On March 4, 2015
2/24/2015
-
3-V Biosciences To Present At Cowen and Company 35th Annual Health Care Conference On March 4, 2015
2/24/2015
-
Pharmacyte Biotech Initiates Expanded Follow-Up Study In The United States On The Accumulation Of Malignant Ascites Fluid
2/19/2015
-
Sunshine Heart Locks in $10 Million
2/19/2015
-
3-V Biosciences Appoints Rekha Hemrajani As Chief Financial Officer
2/19/2015
-
PharmaCyte Biotech Diabetes Consortium Member Publishes Review Article On Use Of Genetic Engineering To Treat Diabetes
2/13/2015
-
Sunshine Heart Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
2/13/2015
-
Nexvet Biopharma Announces Closing Of Initial Public Offering
2/11/2015
-
Blueprint Medicines Appoints Anthony Boral, M.D., Ph.D., As Senior Vice President, Clinical Development
2/11/2015
-
Agendia BV Receives New FDA Clearance for MammaPrint FFPE Breast Cancer Test
2/10/2015
-
Pharmacyte Biotech's International Diabetes Consortium Sets Path Forward To Develop Novel Treatment For Diabetes
2/10/2015
-
Proteostasis Therapeutics, Inc. Announces A New Class Of Agents For Cystic Fibrosis Called CFTR Amplifiers And Selects PTI130 As A Development Candidate
2/5/2015
-
Pharmacyte Biotech Initiates First Preclinical Study Of Its Encapsulated Cell Product For Novel Treatment Of Diabetes
2/2/2015